Device Trial Radar · NCT00788671
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
69
Actual
Start
Nov 3, 2008
Primary completion
Jun 10, 2016
Study completion Nov 30, 2027
Sponsor
- Lead sponsor
- M.D. Anderson Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Nov 11, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well levonorgestrel-releasing intrauterine system works in treating patients with complex atypical hyperplasia or grade I endometrial cancer. High levels of estrogen can cause the growth of endometrial cancer cells. Progesterone can help balance the amount of estrogen present. Hormone therapy using levonorgestrel, a type of progesterone, may fight endometrial cancer by helping regulate hormone levels.
Conditions
- Atypical Endometrial Hyperplasia
- Stage I Uterine Corpus Cancer AJCC v7
- Stage IA Uterine Corpus Cancer AJCC v7
- Stage IB Uterine Corpus Cancer AJCC v7
- Stage II Uterine Corpus Cancer AJCC v7
Interventions
Laboratory Biomarker AnalysisOther
Correlative studies
Levonorgestrel-Releasing Intrauterine SystemDevice
Undergo placement of a levonorgestrel-releasing intrauterine system
Quality-of-Life AssessmentOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response Rate at 12 MonthTime frame: At 1 year
- Efficacy of the Levonorgestrel Intrauterine Device (IUD)Time frame: At 1 year
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Lyndon Baines Johnson General Hospital
Houston, Texas
M D Anderson Cancer Center
Houston, Texas
The Woman's Hospital of Texas
Houston, Texas
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.